Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARG | P13631 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29326901 | 0.89 | CA1 (0.32) | — | |
| SCHEMBL18186091 | 0.88 | CA1 (0.33) | — | |
| SCHEMBL19754902 | 0.87 | — | — | |
| SCHEMBL18186086 | 0.87 | RARG (0.33) | RARGRXRAPPARG | |
| SCHEMBL16987219 | 0.86 | CA1 (0.35) | — | |
| SCHEMBL18673560 | 0.85 | — | — | |
| SCHEMBL18670913 | 0.84 | CA1 (0.32) | — | |
| SCHEMBL17126986 | 0.84 | ALDH1A1 (0.30) | — | |
| SCHEMBL17280440 | 0.84 | — | — | |
| SCHEMBL16996690 | 0.84 | CA1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3145938-B1 | METHOD FOR PRODUCING MONOPHOSPITES | EVONIK DEGUSSA GMBH (DE) | 2018-12-26 | — | — | EP | disclosed |
| EP-3088405-B1 | NOVEL MONOPHOSPHIT COMPOUNDS WITH A METHYL GROUP | EVONIK DEGUSSA GMBH (DE) | 2018-11-14 | — | — | EP | disclosed |
| US-9605010-B2 | Monophosphite compounds having a methyl group | EVONIK DEGUSSA GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9605010-B2 | Monophosphite compounds having a methyl group | EVONIK DEGUSSA GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9605011-B2 | Monophosphite compounds having an ether group | EVONIK DEGUSSA GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9605011-B2 | Monophosphite compounds having an ether group | EVONIK DEGUSSA GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9605011-B2 | Monophosphite compounds having an ether group | EVONIK DEGUSSA GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9605010-B2 | Monophosphite compounds having a methyl group | EVONIK DEGUSSA GMBH (DE) | 2017-03-28 | — | — | US | disclosed |
| US-20160318959-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING A METHYL GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160318959-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING A METHYL GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160318959-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING A METHYL GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160318960-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING AN ETHER GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160318960-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING AN ETHER GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160318960-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING AN ETHER GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| EP-3088405-A1 | NOVEL MONOPHOSPHIT COMPOUNDS WITH A METHYL GROUP | Evonik Degussa GmbH (DE) | 2016-11-02 | — | — | EP | disclosed |
| EP-3088406-A1 | NOVEL MONOPHOSPHIT COMPOUNDS WITH AN ETHER GROUP | Evonik Degussa GmbH (DE) | 2016-11-02 | — | — | EP | disclosed |
| EP-3088405-A1 | NOVEL MONOPHOSPHIT COMPOUNDS WITH A METHYL GROUP | Evonik Degussa GmbH (DE) | 2016-11-02 | — | — | EP | disclosed |
| EP-3088406-A1 | NOVEL MONOPHOSPHIT COMPOUNDS WITH AN ETHER GROUP | Evonik Degussa GmbH (DE) | 2016-11-02 | — | — | EP | disclosed |
| WO-2015176928-A1 | METHOD FOR PRODUCING MONOPHOSPITES | EVONIK DEGUSSA GMBH (DE) | 2015-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318960-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING AN ETHER GROUP | NUDT1, PHOSPHO1, NUDT14 | RARG 1329/4885RXRA 2857/4885PPARG 3573/4885 |
| US-20160318959-A1 | NOVEL MONOPHOSPHITE COMPOUNDS HAVING A METHYL GROUP | NUDT1, MTAP, MPHOSPH6 | RARG 2046/4885RXRA 3968/4885PPARG 4614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.